FAM-Phe-CMK Serine Protease Assay Kit Summary
| Description |
Detect changes in intracellular chymotrypsin-like enzyme activity in whole living cells with the FLISP, Fluorescent-Labeled Inhibitors of Serine Proteases, product line of assay kits. These kits utilize either a leucine (L) or phenylalanine (F) chymotrypsin-targeting amino acid residue linked on the amino terminus with either a carboxyfluorescein (FAM) or sulforhodamine 101 (SR) fluorescent reporter tag. The carboxyl end of the F or L amino acid residue contains a reactive group that targets the catalytic site of serine proteases, consisting of either a chloromethyl ketone (CMK) or (aminoalkyl) phosphonate diphenyl ester (DAP) reactive group. |
| PreparationMethod |
Target: chymotrypsin-like enzymes
Excitation / Emission: 488 nm / 530 nm
Method of Analysis: Flow Cytometer, Fluorescence Microscope, Fluorescence Plate Reader
Types of Samples: cell culture, tissue |
| Kit Type |
Assay Kit |
Packaging, Storage & Formulations
| Storage |
Storage of components varies. See protocol for specific instructions. |
Applications/Dilutions
| Application Notes |
Detect changes in intracellular chymotrypsin-like enzyme activity in whole living cells with the FLISP (TM), Fluorescent-Labeled Inhibitors of Serine Proteases, product line of assay kits. These kits utilize either a leucine (L) or phenylalanine (F) chymotrypsin-targeting amino acid residue linked on the amino terminus with either a carboxyfluorescein (FAM) or sulforhodamine 101 (SR) fluorescent reporter tag. The carboxyl end of the F or L amino acid residue contains a reactive group that targets the catalytic site of serine proteases, consisting of either a chloromethyl ketone (CMK) or (aminoalkyl) phosphonate diphenyl ester (DAP) reactive group. After quickly penetrating the lipid bilayer membranes of the target cell population, the chymotrypsin-targeting FLISP(TM), probes will interact with the active catalytic sites of chymotrypsin-like proteases, quickly forming covalent bonds with either the reactive site histidine (N-H) (with the CMK-type FLISP probes) or the reactive serine OH group (when DAP-containing FLISP probes are utilized). In either case, unbound FLISP reagent is easily removed during the wash step, leaving cells with greater quantities of active chymotrypsin-like enzyme activity with a greater fluorescence potential than cells that did not undergo an upregulation of serine protease activity. FLISP probes bearing FAM reporter dyes are excited at 488 nm and emit in the green wavelength range of 525 nm. The red fluorescence FLISP probes that utilize sulforhodamine 101 as the reporter dye are excited at 590 nm and emit at 620 nm. FLISP probes are cell permeant and non-cytotoxic at the concentrations suggested in the assay protocol. The FLISP FAM-Phe-CMK (FFCK) chymotrypsin enzyme detection assay kits can be used in conjunction with existing apoptosis detection protocols. They have been used successfully in tandem with the SR (red) FLICA caspase detection assay kits to show a parallel upregulation of chymotrypsin-like enzyme activity and caspase activation. Each kit includes the FLISP FFCK reagent, 10x wash buffer for removing excess FLISP probe following the FLISP incubation step, 10X fixative to stabilize cells if next day analysis is preferred, Propidium Iodide vital stain for necrotic cell detection, and Hoechst 33342 dye to visualize nuclear morphology. FLISP FFCK-stained cells may be analyzed using flow cytometry, fluorescence microscopy, and fluorescence plate reader evaluation methodology. |
| Publications |
| Read Publications using NBP2-31123 in the following applications: |
|
Kit Components
|
Components
|
- FAM-Phe-CMK (four 25-test vials)
- Hoechst Stain (1 mL)
- Propidium Iodide (1 mL)
- 10x FLISP Wash Buffer (15 mL)
|
Reactivity Notes
Human reactivity reported in scientific literature (PMID: 25734483)
Alternate Names for FAM-Phe-CMK Serine Protease Assay Kit
- FAM-F-CMK chymotrypsin-like protein
- FAM-F-CMK FLISP
- FAM-spacer-Phe-CMK
- FLISP FAM-Phe-CMK Serine Protease
Background
Chymotrypsin like enzymes cleave their substrate proteins at the carboxy terminal end of amino acids containing hydrophobic aliphatic or aromatic R-group side chains such as those found on leucine and phenylalanine amino acid structures. The FFCK FLISP probe, consisting of FAM-F-CMK, is simply a fluorescent-labeled analog of the early chymotrypsin-like enzyme inhibitor N-tosyl-L-phenylalanine chloromethyl ketone (TPCK). Early studies using topoisomerase inhibitors in HL-60 cells indicated that TPCK, N-tosyl-L-lysine chloromethyl ketone (TLCK) and other serine protease inhibitors, were able to prevent internucleosomal DNA degradation associated with apoptosis [3]. Dual staining experiments have used this FAM-F-CMK chymotrypsin detection probe and the sulforhodamine (SR)-VAD-FMK FLICA caspase detection probe in the presence or absence of z-VAD-FMK, TPCK, or TLCK caspase or serine protease inhibitors. This work demonstrated a significant inhibitory effect of the caspase inhibitor, z-VAD-FMK, on chymotrypsin associated FAM-F-CMK binding in cells. This group also showed that the chymotrypsin-like enzyme inhibitor, TPCK, had a strong suppressive effect on caspase activation and apoptosis induction. In contrast, the trypsin-like enzyme inhibitor, TLCK, had very little effect on caspase activation events as measured by the binding of the red FLICA probe SR-VAD-FMK in camptothecin induced cell populations. The FAM-F-CMK chymotrypsin-like protein affinity label was also utilized to analyze upregulated serine protease activity resulting from staurosporine induction in HL-60 and Jurkat cells. In staurosporine-induced Jurkat cells, the FAM-F-CMK specifically labeled an upregulated, constitutively expressed, 60 kDa protein as well as a 50 kDa protein that was only detected in staurosporine-treated Jurkat cells. In a related study using staurosporine-induced HL-60 cells, a 16 kDa protein was detected by the FAM-F-CMK FLISP probe.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Kits are guaranteed for 6 months from date of receipt.
Publications for FAM-Phe-CMK Serine Protease Kit (NBP2-31123)(5)
We have publications tested in 1 confirmed species: Human.We have publications tested in 3 applications: FLOW, Flow-IC, ICC/IF.
Submit a Publication
Filter By Application
FLOW (1)
Flow-IC (2)
ICC/IF (1)
All Applications
Filter By Species
Human (1)
All Species
Showing Publications 1 -
5 of 5.
| Publications using NBP2-31123 |
Applications |
Species |
|---|
| Martinez-Torres AC, Quiney C, Attout T et al. CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLC-gamma1 Activation: Evidence from Mice and Humans PLoS Med. 2015 Mar 01 [PMID: 25734483] (FLOW, Human) |
FLOW |
Human |
| Hadji A, Clybouw C, Auffredou MT et al. Caspase-3 triggers a TPCK-sensitive protease pathway leading to degradation of the BH3-only protein puma. Apoptosis. 2010 Dec [PMID: 20640889]Details:NOXA mAb (Cat no IMG-349A): WB (Fig 1E) SerPase Kit: FAM-Phe-CMK (FFCK) (Cat no IMG-2301-25/-100): Flow (Intracellular), Fig 5C Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein. Fig 5C (HeLa cell extract): caspase activity was measure in the presence and absence of the Z-DEVD-FMK inhibitor (IMI-2312). |
|
|
| Barbier S, Chatre L, Bras M et al. Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica. 2009 Apr [PMID: 19278964] (Flow-IC)Details:Flow (Intracellular): Fig 1F (B lymphocytes from CLL patients treated/untreated with CD47A mAb). |
Flow-IC |
|
| Merle-Beral H, Barbier S, Roue G et al. Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia. Leukemia. 2009 May [PMID: 19005478] (Flow-IC)Details:Flow (Intracellular): Fig 1E (B lymphocytes from CLL patients treated/untreated with CD47A mAb in the presence/absence of 3-MA. 3-MA is an inhibitor of autophagic type II PCD). |
Flow-IC |
|
| Bras M, Yuste VJ, Roue G et al. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol. 2007 Oct [PMID: 17682056] (ICC/IF)Details:B lymphocytes from CLL (Fig 2D, E) and normal (Fig 2E) donors. IF, Fig 2D; Flow (Intracellular), Fig 2E. |
ICC/IF |
|
Reviews for FAM-Phe-CMK Serine Protease Kit (NBP2-31123) (0)
There are no reviews for FAM-Phe-CMK Serine Protease Kit (NBP2-31123).
By submitting a review earn points towards our Rewards Program.
- 250 points for product review
- 500 additional points for an image with your product review
- Double points (500) if you are the first to review this product
- Double points (1000) if you are the first to review this product with an image
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Flow Cytometry
- View all Protocols, Troubleshooting, Illustrated assays and Webinars.
FAQs for FAM-Phe-CMK Serine Protease Kit (NBP2-31123) (0)
There are no specific FAQs related to this product.
Read our general customer & technical service FAQs.
Blogs on FAM-Phe-CMK Serine Protease
There are no specific blogs for FAM-Phe-CMK Serine Protease, but you can read our latest blog posts.